Autoplaque vs cvi42 Auto Imaging
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is highly specialized, AI-powered quantitative analysis of coronary plaques and luminal stenoses exclusively from CT angiography images. This workstation-based tool is ideal for clinicians focused on precise heart attack risk prediction and guiding treatment decisions based solely on coronary CTA findings.
View Autoplaque →Choose cvi42 Auto Imaging if…
Choose cvi42 Auto Imaging if you require a comprehensive, multi-modality solution for analyzing both cardiovascular MR and CT images across a wider range of applications. This tool is best suited for practices needing to streamline clinical workflows with AI-enabled automated contouring, detailed cardiac function analysis (MR), vascular assessment, and integrated smart reporting for a holistic view of cardiovascular health.
View cvi42 Auto Imaging →For a physician evaluating AI tools for cardiovascular imaging, Autoplaque and cvi42 Auto Imaging offer distinct strengths. Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared workstation-based software specifically designed for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. Its core utility lies in aiding heart attack risk prediction and treatment guidance through automated vessel, plaque, and lumen segmentation, which clinicians can review and edit. This tool is best suited for cardiologists or radiologists primarily focused on detailed coronary plaque assessment from CTAs.
In contrast, cvi42 Auto Imaging by Circle Cardiovascular Imaging provides a more comprehensive, multi-modality approach, analyzing both cardiovascular MR and CT images. While it also offers plaque quantification, its feature set extends to cardiac MR analysis (function, flow, tissue characterization, strain) and vascular CT analysis, alongside robust 3D visualization and simplified reporting. The key practical difference is Autoplaque’s specialized focus on coronary CTA plaque analysis versus cvi42 Auto Imaging’s broader, multi-modality cardiovascular imaging capabilities. Physicians whose practice demands extensive analysis across various cardiovascular imaging modalities, including MR, would find cvi42 Auto Imaging more versatile, while those with a primary need for in-depth, quantitative coronary CTA plaque assessment may prefer Autoplaque’s specialized functionality.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | cvi42 Auto Imaging |
|---|---|---|
| Pricing | Not disclosed | Contact for pricing |
| Deployment | Workstation-based software, runs on Windows or Mac computer platforms | On-premise, Stand-alone, Networked environment. Cloud compatibility is mentioned as a feature, but recent FDA clearances for modules like cvi42 | Plaque emphasize on-premise deployment for data control. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
cvi42 Auto Imagingcvi42 Auto Imaging (Tool B) emphasizes an 'unmatched user experience' with 'simplified and smart reporting with infographics and CAD-RADS classification,' indicating a strong focus on intuitive interpretation and streamlined workflows. While Autoplaque (Tool A) offers reviewable and editable segmentation, cvi42's broader approach to user-friendly reporting and multi-modality support suggests a more refined and comprehensive usability design for daily clinical practice.
Clinical Value
cvi42 Auto Imagingcvi42 Auto Imaging (Tool B) offers a broader clinical value by providing comprehensive analysis across both MR and CT images, including cardiac function, flow, tissue characterization, strain, and vascular CT, in addition to plaque assessment. Autoplaque (Tool A) is more narrowly focused on quantitative analysis of coronary plaques and luminal stenoses from CT angiography, despite its strong clinical validation. The multi-modality and extensive analytical capabilities of cvi42 provide a more holistic view for cardiovascular diagnosis and treatment planning.
Pricing & Value
cvi42 Auto ImagingBoth tools have undisclosed pricing. However, cvi42 Auto Imaging (Tool B) provides more insight into its pricing model, mentioning a flexible 'Elevate pricing structure' that scales with usage and offers modular licensing. This modularity and volume-aligned pricing, combined with its ability to help sites retain reimbursement for AI-enabled plaque analysis, suggests a more adaptable and potentially higher value proposition for various clinical settings.
Enterprise Readiness
cvi42 Auto Imagingcvi42 Auto Imaging (Tool B) demonstrates superior enterprise readiness with explicit support for networked environments, cloud compatibility, and simplified integrations with PACS/VNA, EMR, DICOM, and HL7. Its widespread adoption in over 1,700 hospitals globally further highlights its proven ability to integrate into diverse healthcare IT infrastructures. Autoplaque (Tool A), described primarily as workstation-based, appears less geared for broad enterprise deployment.
Innovation
cvi42 Auto ImagingWhile both tools leverage AI for automated analysis, cvi42 Auto Imaging (Tool B) demonstrates broader innovation through its multi-modality and vendor-neutral platform, advanced reporting with CAD-RADS classification, and continuous expansion into new areas like vascular CT analysis and CT Strain. Its focus on a unified platform that integrates diverse AI-driven workflows across multiple imaging types showcases a more comprehensive and evolving innovative strategy.
Support & Docs
cvi42 Auto Imagingcvi42 Auto Imaging (Tool B) clearly excels in this dimension, explicitly detailing various support channels including live chat, email, phone, and comprehensive documentation such as help guides, webinars, and on-site training. The company also highlights its global team, commitment to customer service, and industry-leading satisfaction scores. Autoplaque (Tool A) has no publicly available information on its support structure or documentation beyond a user manual.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | cvi42 Auto Imaging |
|---|---|---|
| Product Name | Autoplaque | cvi42 Auto Imaging |
| Company | Cedars-Sinai Medical Center: AIM | Circle Cardiovascular Imaging |
| Primary Imaging Modalities | CT angiography images | Cardiovascular MR and CT images (Multi-modality support: MR, CT) |
| Core Analysis Capabilities | AI-powered quantitative analysis of atherosclerotic plaque, detection and characterization of coronary artery plaque, measurement of luminal stenoses, analysis of coronary anatomy and pathology from CT Angiographic images, measurement of vessel diameter and area. | Comprehensive analysis of cardiovascular MR and CT images, precise diagnosis, plaque quantification, Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain), Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment), Vascular CT analysis (diagnosis, planning, surveillance), Quantitative analysis (volume, mass, function, signal intensity, plaque). |
| Automated Segmentation/Contouring | Automated vessel, plaque, and lumen segmentation (reviewable and editable by clinician) | AI-enabled automated contouring and segmentation |
| Supported Specialties | Cardiology, Radiology | Cardiology, Radiology, Vascular Surgery |
| Reporting Features | Not specified | Simplified and smart reporting with infographics and CAD-RADS classification |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and cvi42 Auto Imaging.